Globus Medical (GMED) PT Raised to $78 at RBC Capital
RBC Capital analyst Shagun Singh raised the price target on Globus Medical (NYSE: GMED) to $78.00 (from $76.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
